With the Magnetom Spectra, Siemens Healthcare plans to make 3-Tesla MRI technology more readily available to smaller and mid-size practices and imaging centers.
Siemens Healthcare announced this week plans to make 3-Tesla MRI technology more readily available through a lower cost system. The Magnetom Spectra, will be marketed to smaller and mid-size practices and imaging centers.
“Innovation doesn’t necessarily mean you always do everything great, better and then more expensive,” Bernd Ohnesorge, CEO of the Siemens MR business unit, said in an interview. Instead, Siemens is making the MRI system available to a broader patient population by reducing the total cost of ownership.
The target market of 3-T MRI upon its release five years ago was the research community and high-level clinical care centers, Ohnesorge said. “Now with the growing demand and high maturity, we believe it’s very important to offer an innovation to the market to have this imaging performance enter smaller hospitals and community hospitals and imaging centers,” he said.
The company announced the system in advance of ECR 2012 next week.
The company is able to offer the system at a lower total cost of ownership because they are “optimizing individual components and cost structures,” Ohnesorge explained. Compared with the first appearance of 3-T MRI three years ago, this system is two times more affordable over its 10-year lifecycle.
The Magnetom Spectra employs Siemens’ Total imaging matrix 4G coil, which allows for high spatial and temporal resolution, according to the company. The cable-less direct-connect coils allow for easy setup, and up to 120 coil elements can be combined in a flexible manner, allowing for large whole-body scans up to 205 cm. Siemens’ MRI workflow solution Dot, day optimizing throughput, is also included.
“We want to make sure we have an answer to this demand of offering this 3-T performance at a much better cost performance point, so many more can have access to it,” Ohnesorge said. “We believe it will accelerate the adoption rate of 3-T MRI in a broad clinical base.”
The system is in operation at sites in Germany and China, and the company expects it to be available in the U.S. later this year, pending FDA approval.
Images courtesy Siemens AG
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 2
July 25th 2025In the second of a multi-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, share their perspectives on remote MRI safety protocols for ensuring screening accuracy and adherence to conditional implant guidelines as well as a rapid and effective response to adverse events.
Study Reveals Significant Prevalence of Abnormal PET/MRI and Dual-Energy CT Findings with Long Covid
July 22nd 2025In a prospective study involving nearly 100 patients with Long Covid, 57 percent of patients had PET/MRI abnormalities and 90 percent of the cohort had abnormalities on dual-energy CT scans.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 2
July 23rd 2025In the second part of a multi-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, discuss key sequences for abbreviated breast MRI and how it stacks up to other breast cancer screening modalities.
Stroke MRI Study Assesses Impact of Motion Artifacts Upon AI and Radiologist Lesion Detection
July 16th 2025Noting a 7.4 percent incidence of motion artifacts on brain MRI scans for suspected stroke patients, the authors of a new study found that motion artifacts can reduce radiologist and AI accuracy for detecting hemorrhagic lesions.